Your browser doesn't support javascript.
loading
[Hyperferritinemia in a Chilean Academic Healthcare Network: A Retrospective Study]. / Hiperferritinemia: Experiencia de un Centro Universitario en Chile.
Huenur F, Julieth; Parodi C, María; Aravena G, Carmen; Eymin L, Gonzalo; Triantafilo C, Nicolás; Walkowiak N, Stefan; Valenzuela S, Andrés; Corsi S, Óscar.
Afiliación
  • Huenur F J; Escuela de Medicina, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Parodi C M; Escuela de Medicina, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Aravena G C; Unidad de Paciente Crítico, Hospital de Urgencia Asistencia Pública, Santiago, Chile.
  • Eymin L G; Escuela de Medicina, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Triantafilo C N; Escuela de Medicina, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Walkowiak N S; Facultad de Medicina, Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.
  • Valenzuela S A; Escuela de Medicina, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Corsi S Ó; Escuela de Medicina, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Rev Med Chil ; 151(4): 412-419, 2023 Apr.
Article en Es | MEDLINE | ID: mdl-38687515
ABSTRACT

INTRODUCTION:

The distribution of causes of hyperferritinemia in international series is heterogeneous. Also, the association between ferritin and prognosis is controversial. This study aims to describe the diagnosis associated with hyperferritinemia in a retrospective cohort at an academic healthcare network in Chile.

METHODS:

A retrospective review of adult patients admitted to our academic medical center from June 2014 to February 2017 with ferritin ≥3,000 ng/mL. All patients were classified into nine diagnostic categories. Then, the association between ferritin level and disease category, as well as mortality, was evaluated.

RESULTS:

Ninety-nine patients were identified. The mean age was 50.8 ± 19.9 years, 54.5% were men. The most frequent categories were "inflammatory and autoimmune diseases" (21.2%) and "hematological malignancies" (19.2%). The average ferritin was 10,539 ± 13,016.9 ng/mL, while the higher mean was 16,707 ng/mL in the "inflammatory and autoimmune diseases" category. There was a statistically significant association between the ferritin value and age but not between ferritin and diagnostic categories. In the group over 50, hematologic neoplasms (19%) and infections (19%) were more frequent. In those under 50, inflammatory and autoimmune diseases were more frequent (26.8%). There was no association between the ferritin level and mortality at 1, 3, and 12 months.

CONCLUSIONS:

The most frequent categories were "inflammatory and autoimmune diseases" and "hematological malignancies", but ferritin level was similar in both. Further research could validate a prognostic role.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ferritinas / Hiperferritinemia Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do sul / Chile Idioma: Es Revista: Rev Med Chil Año: 2023 Tipo del documento: Article País de afiliación: Chile Pais de publicación: Chile

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ferritinas / Hiperferritinemia Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do sul / Chile Idioma: Es Revista: Rev Med Chil Año: 2023 Tipo del documento: Article País de afiliación: Chile Pais de publicación: Chile